Increasing Prevalence Of Osteoporosis Fueling The Growth Of The Market Due To Aging Population And Rising Fracture Risks Is Supporting Development Across The Calcitonin Injection Market

The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

What Is The Expected Market Value Outlook For The Calcitonin Injection Market Through 2030?

The market size for calcitonin injections has shown strong growth in recent years. It is projected to expand from $0.73 billion in 2025 to $0.79 billion in 2026, advancing at a compound annual growth rate (CAGR) of 8.4%. Factors such as osteoporosis prevalence, hospital injectable therapies, fracture management protocols, calcium metabolism disorders, and an aging population are identified as contributors to its historical growth.

The calcitonin injection market is projected to experience substantial expansion in the coming years. This market is set to reach $1.07 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 8.1%. Factors contributing to this anticipated growth during the forecast period include an increasing elderly population, a rising demand for injectable treatments, heightened awareness of bone diseases, advancements in synthetic peptide development, and the expansion of specialty care services. Key developments expected during this period involve the sustained application in osteoporosis management, the proliferation of injectable therapies for bone conditions, the broadening of hypercalcemia treatment options, an increased focus on bone health in the elderly, and a shift towards synthetic calcitonin formulations.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24490&type=smp

What Influential Factors Are Boosting The Calcitonin Injection Market Demand?

The rising incidence of osteoporosis is projected to boost the calcitonin injection market. Osteoporosis is a medical condition marked by reduced bone density and a greater likelihood of fractures, mainly impacting older individuals, particularly women after menopause. This rise in osteoporosis cases is linked to an aging global population, where increased longevity naturally results in bone density loss and a higher risk of developing the condition. Calcitonin injections support osteoporosis treatment by managing calcium levels and slowing bone deterioration, thereby effectively preserving bone density. These injections offer a focused treatment that is simple to administer, which enhances patient adherence and lowers the risk of fractures. For example, in August 2024, data from Healthy Bones Australia, an Australian non-profit dedicated to osteoporosis prevention and bone health, revealed that an estimated 6.2 million Australians aged 50 and above—approximately 67 percent of this demographic—experienced poor bone health in 2023, with around 23 percent of them suffering from osteoporosis. Consequently, the growing prevalence of osteoporosis is stimulating expansion in the calcitonin injection market.

Calcitonin Injection Market Driver: Expansion Of Home Healthcare Services Fuelling The Growth Of The Market Amid The Accelerating Transition From Hospital To Home-Based Care

How Is The Calcitonin Injection Market Distributed Across Key Segments?

The calcitonin injection market covered in this report is segmented –

1) By Type Of Calcitonin: Salmon Calcitonin, Human Calcitonin, Synthetic Calcitonin

2) By Route Of Administration: Intravenous (IV) Injection, Subcutaneous Injection, Intramuscular Injection

3) By Distribution Channel: Direct Sales, Online Pharmacy, Retail Pharmacy, Healthcare Institutions

4) By Therapeutic Application: Osteoporosis Treatment, Pagets Disease Management, Hypercalcemia Control, Bone Metastases Therapy

5) By End-User: Hospitals, Specialty Clinics, Geriatric Care Facilities, Home Healthcare

Subsegments:

1) By Salmon Calcitonin, Synthetic Salmon Calcitonin, Recombinant Salmon Calcitonin

2) By Human Calcitonin, Recombinant Human Calcitonin, Synthetic Human Calcitonin

3) By Synthetic Calcitonin, Peptide-Based Synthetic Calcitonin, Analog Synthetic Calcitonin

Which Trends Are Influencing The Expansion Of The Calcitonin Injection Market?

Leading companies in the calcitonin injection market are concentrating on developing innovative products, such as USP synthetic injections, to boost treatment effectiveness and improve patient outcomes. USP Synthetic Injections are injectable medications containing synthetically produced active ingredients that adhere to the stringent quality, purity, strength, and identity standards set by the United States Pharmacopeia (USP). These injections are manufactured under regulated conditions to ensure their safety and effectiveness for therapeutic use. For instance, in February 2025, Fresenius Kabi, a Germany-based pharmaceutical company, launched calcitonin salmon injection, a USP synthetic, for treating symptomatic Paget’s disease of the bone and hypercalcemia. It is a sterile solution designed for intramuscular or subcutaneous injection, available with a strength of 200 USP units per mL and packaged in a 2 mL multi-dose vial containing 400 USP units. It requires refrigerated storage between 2°C and 8°C. This injectable medication functions as a calcium regulator and is indicated for the treatment of symptomatic Paget’s disease of bone when alternative treatments are unsuitable, hypercalcemia, and postmenopausal osteoporosis when other options are not appropriate.

Who Are The Firms Contributing To The Calcitonin Injection Market Ecosystem?

Major companies operating in the calcitonin injection market are Pfizer Inc., AbbVie Inc., Teva Pharmaceutical Industries Ltd., Lupin Limited, Aurobindo Pharma Limited, Zydus Lifesciences Limited, Glenmark Pharmaceuticals Limited, Alembic Pharmaceuticals Limited, Alkem Laboratories Limited, Intas Pharmaceuticals Limited, Emcure Pharmaceuticals Limited, Wockhardt Limited, Accord Healthcare Ltd., Sandoz International GmbH, Amneal Pharmaceuticals LLC, Apotex Inc., Mylan N.V., Cadila Pharmaceuticals Limited, Macleods Pharmaceuticals Ltd., Bharat Parenterals Limited

Access The Complete Calcitonin Injection Market Report:

https://www.thebusinessresearchcompany.com/report/calcitonin-injection-global-market-report

Which Region Commands The Largest Share Of The Calcitonin Injection Market?

North America was the largest region in the calcitonin injection market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the calcitonin injection market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Calcitonin Injection Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/sample.aspx?id=24490&type=smp

Browse Through More Reports Similar to the Global Calcitonin Injection Market 2026, By The Business Research Company

Companion Animal Pharmaceuticals Market Report 2026

https://www.thebusinessresearchcompany.com/report/companion-animal-pharmaceuticals-global-market-report

Pharmaceutical Excipient Market Report 2026

https://www.thebusinessresearchcompany.com/report/pharmaceutical-excipient-global-market-report

Pharmaceutical Drug Delivery Market Report 2026

https://www.thebusinessresearchcompany.com/report/pharmaceutical-drug-delivery-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795